More than 80 pharmaceutical companies have called on governments to develop new ways of paying them to develop antibiotics. With drug-resistant microbes predicted to kill 10 million people a year by 2050 and cost $100 trillion in lost economic output, Redx Pharm chief executive said “there is a doomsday clock ticking, with the effectiveness of antibiotics diminishing at an alarming rate, new ways must be found to support innovation and drug discovery in this critical area”.

New test can identify dangerous bacteria with resistance to last-resort antibiotic

New research suggests it is possible to quickly…

FDA ajusta la “fórmula” de Kisunla para hacerlo más seguro

La FDA aprobó un cambio en las instrucciones de…

Webinar: Local Antibiotic Carrier for the Management of Spine Infections

Tema   Webinar: Local Antibiotic Carrier…

New approach may give new life to old antibiotic

Medical News Today recently featured a study…

Treating COVID-19: Are we overusing antimicrobials?

Medical News Today recently reported on a study…

5 key factors expected to bring the total knee replacement market value to $14.9B by 2030

5 key factors expected to bring the total knee…

Life expectancy to break 90 barrier by 2030

A study by Imperial College London and the World…

Pharma ‘cash call’ for new antibiotics

More than 80 pharmaceutical companies have…

Current Use of Bone Substitutes in Maxillofacial Surgery

sulfato-de-calcio-en-cirugia-p…